A METHOD FOR PREDICTING UNFAVORABLE OUTCOME OF TREATMENT IN PATIENTS WITH RIFAMPICIN-RESISTANT PULMONARY TUBERCULOSIS
Patent Information
- Authority / Receiving Office
- EA · EA
- Patent Type
- Patents
- Current Assignee / Owner
- GOSUDARSTVENNOE UCHREZHDENIE RESPUBLIKANSKIY NAUCHNO PRAKTICHESKIY TSENTR PULMONOLOGII I FTIZIATRII
- Filing Date
- 2025-06-26
- Publication Date
- 2026-07-15
Smart Images

Figure CLAIM-15072026-IMGC0001
Abstract
Claims
A method for predicting an unfavorable treatment outcome in patients with rifampicin-resistant pulmonary tuberculosis, including drug therapy, bacteriological testing with the identification of predictors of an unfavorable treatment outcome, one of which is the time to sputum culture conversion, characterized in that after the bacteriological testing, atomic force microscopy is performed and the rigidity of the cell wall of Mycobacterium tuberculosis is used as an additional predictor with the determination of its coefficient, after which a calculation is made using the formula: where p is the probability of an unfavorable outcome, %, e is the base of the natural logarithm, z = -10.048 + 0.086 × x1 + 0.073 × x2, where z is a linear predictor, -10.048 is the model constant, 0.086 is the coefficient of the first variable, x1 - coefficient of rigidity of the cell wall of Mycobacterium tuberculosis, pN / μm, 0.073 is the coefficient of the second variable, x2 - time to sputum culture conversion, days, and draw the following conclusions: if p is less than 54.1%, a low probability of an unfavorable treatment outcome is predicted; if p is greater than or equal to 54.1%, a high probability of an unfavorable treatment outcome is predicted.